The SURMOUNT-1 trial published in the New England Journal of Medicine (Jastreboff et al., 2022) showed average weight loss of 20.9 percent of body weight at the highest tirzepatide dose over 72 weeks
At Skin Artisans, we witness these transformations every day
For a class of drugs already transforming millions of lives, this approach could further enhance both efficacy and tolerability, underscoring that responses to GLP-1 therapies are shaped not only by pharmacology but also by the subtle variations of the human genome
Moreover, elevated seminal IL-1 levels are strongly associated with decreased mitochondrial activity in sperm, suggesting that pro-inflammatory cytokines not only originate from testicular inflammation but also act within the seminal microenvironment to damage mature sperm (73)
Graphical Abstract 1
No inference should be drawn regarding human wound healing, tissue repair, therapeutic efficacy, safety, or suitability for any human, cosmetic, wellness, fitness, or veterinary application